• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about EXEL

Recent news which mentions EXEL

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Can This Cancer Stock Maintain Its Momentum?
May 18, 2022
Tickers EXEL
Tags EXEL Recent Press Releases Market News
From Motley Fool
Buying These 3 Stocks Could Be the Smartest Investing Move You Ever Make
May 17, 2022
Tickers BMY ETSY EXEL IPSEY
Tags IPSEY EXEL Recent Press Releases
From Motley Fool
Exelixis (EXEL) Q1 2022 Earnings Call Transcript
May 11, 2022
Tickers EXEL
Tags Recent Press Releases Market News EXEL
From Motley Fool
Exelixis: Q1 Earnings Insights
May 10, 2022
Tickers EXEL
Tags EXEL Benzinga BZI/Recaps
From Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Tickers AGEN ARWR ATNX AVGR
Tags AVGR BAYRY AVIR
From Benzinga
3 Growth Stocks to Buy With $1,000 Right Now
May 03, 2022
Tickers BMY CURLF EXEL PINS
Tags EXEL BMY CURLF
From Motley Fool
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Tickers ACAD AQST BIIB BLTE
Tags Small Cap BLTE SESN
From Benzinga
Ipsen - Exelixis' Cabometyx Scores European Approval As Second-Line Treatment For Thyroid Cancer
May 03, 2022
Tickers EXEL IPSEF IPSEY
Tags EXEL IPSEY Briefs
From Benzinga
7 Top-Rated Biotech Stocks to Buy for Q2
April 21, 2022
Tickers BCRX BNTX EXEL ITOS
Tags Stocks to Buy BCRX Market News
From InvestorPlace
Nasdaq Bear Market: 3 of the Safest Stocks to Buy on the Dip
April 13, 2022
Tickers AVGO BRK-A BRK-B EXEL
Tags AVGO Market News Recent Press Releases
From Motley Fool
3 No-Brainer Stocks to Buy With $1,000 During the Market Sell-Off
April 01, 2022
Tickers AVGO EXEL FB
Tags Market News Recent Press Releases AVGO
From Motley Fool
2 Stocks Defying the Market Sell-Off Right Now
March 29, 2022
Tickers BMY EXEL
Tags EXEL BMY Recent Press Releases
From Motley Fool
EMA's Scientific Committee Backs Expanded Use Of Exelixis, Ipsen's Cabometyx In Thyroid Cancer
March 25, 2022
Tickers EXEL IPSEF IPSEY
Tags IPSEF General News
From Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers ALT ANAB ANIP ATHX
Tags Small Cap BTTX AZN
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers BAYRY BAYZF EXEL IPSEY
Tags RHHBY General RHHVF
From Benzinga
3 Stocks That Can Turn $10,000 Into $50,000 by 2025
March 11, 2022
Tickers EXEL FIGS NVAX
Tags FIGS NVAX Recent Press Releases
From Motley Fool
2 Biotech Stocks That Could Make You Richer
March 02, 2022
Tickers BMY EXEL ICPT RHHBY
Tags ICPT EXEL BMY
From Motley Fool
3 Surefire Stocks to Buy Hand Over Fist During the Stock Market Sell-Off
February 25, 2022
Tickers EXEL GM MA
Tags EXEL GM Market News
From Motley Fool
Exelixis (EXEL) Q4 2021 Earnings Call Transcript
February 18, 2022
Tickers EXEL
Tags EXEL Recent Press Releases Market News
From Motley Fool
Exelixis: Q4 Earnings Insights
February 17, 2022
Tickers EXEL
Tags EXEL Benzinga BZI/Recaps
From Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
Tickers AAWW AEE AEL AL
Tags AN YETI LNT
From Benzinga
Earnings Preview For Exelixis
February 16, 2022
Tickers EXEL
Tags EXEL Benzinga Earnings
From Benzinga
Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial
February 15, 2022
Tickers BMY EXEL
Tags Briefs renal cell carcinoma EXEL
From Benzinga
2 Biotech Stocks That Could Make You Richer
February 02, 2022
Tickers BLUE EXEL TSVT
Tags Recent Press Releases TSVT Market News
From Motley Fool
5 Value Stocks That Can Make You Richer in 2022
January 20, 2022
Tickers AGNC EXEL FB GM
Tags Market News AGNC T
From Motley Fool
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
January 14, 2022
Tickers ARKG BMY CRSP EXEL
Tags EXEL ARKG Recent Press Releases
From Motley Fool
A Peek Into The Markets: US Stock Futures Edge Higher; Crude Oil Up 0.5%
January 10, 2022
Tickers ACN AZZ CMC EXEL
Tags CMC News Earnings
From Benzinga
7 of the Best Cheap Stocks Under $20 for 2022 to Buy Now
January 03, 2022
Tickers AAL EXEL MOMO ORAN
Tags SOFI NASDAQ:EXEL,NYSE:ORAN,NASDAQ:VOD,NASDAQ:AAL,NASDAQ:MOMO,NASDAQ:VTRS,NASDAQ:SOFI EXEL
From InvestorPlace
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
Tickers ADAG ALNY ARQT EXEL
Tags FDA ARQT Small Cap
From Benzinga
2 Growth Stocks Analysts Think Can Double Within 2 Years
December 15, 2021
Tickers EXEL FUBO
Tags Market News Recent Press Releases FUBO
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap